je.st
news
Tag: financial
Teck Resources names two new directors with experience in financial services
2014-11-21 18:02:58| Grocery - Topix.net
Teck Resources Ltd. has named the chief risk officer from a major Canadian bank and the managing partner from a private equity firm to its board of directors. The Vancouver-based mining company says each of the two women - Laura Dottori-Attanasio of CIBC and Tracey McVicar of CAI Capital Management - has more than 20 years experience in the financial services industry.
Tags: services
resources
experience
financial
Dubai Refreshments (P.S.C.) : Consumer Packaged Goods - Company Profile, SWOT & Financial Report
2014-11-21 01:00:00| Beverage industry market research - from just-drinks.com
Canadean's "Dubai Refreshments (P.S.C.) : Consumer Packaged Goods - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile c
Tags: company
report
profile
financial
CI Financial Corp Insider Douglas J.R. Jamieson Unloads 10,000 Shares
2014-11-18 19:51:42| Furniture - Topix.net
CI Financial Corp Insider Douglas J.R. Jamieson unloaded 10,000 shares of CI Financial Corp stock on the open market in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $34.09, for a total value of $340,900.00.
Tags: financial
corp
shares
douglas
New Market Research Report: Highwater Ethanol, LLC (HEOL) - Financial ...
2014-11-18 13:00:58| Agriculture - Topix.net
The company produces ethanol by fermenting and distilling grains such as corn, barley and wheat. Highwater Ethanol produces 50 million gallons of ethanol and 160,000 tons of DDG dried distillers grains.
Tags: report
research
market
financial
Bio-Path Holdings Reports Third Quarter 2014 Operational and Financial Results
2014-11-18 11:35:59| Semiconductors - Topix.net
Bio-Path Holdings, Inc., , a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2014. The final patient of cohort six completed treatment in the Phase I clinical trial evaluating Bio-Path's lead product candidate, BP-100-1.01 in blood cancers.
Tags: results
reports
financial
quarter
Sites : [354] [355] [356] [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] [367] [368] [369] [370] [371] [372] [373] next »